Provided that this crossing could occur, metformin may become a therapeutic agent not only in peripheral and diabetes-associated vascular neuropathy but also in neurodegenerative diseases.Metformin and cancerPatients with type 2 diabetes have increased risks of various types of cancer, particularly liver, pancreas, endometrium, colon, rectum, breast, and bladder cancer.